Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX/ERCC1 gene expression

References

• Aardema MJ, Snyder RD, Spicer C, Divi K, Morita T, Mauthe RJ, Gibson DP, Soelter S, Curry PT, Thybaud V, et al. 2006. SFTG international collaborative study on in vitro micronucleus test III. Using CHO cells. Mutat Res. 607:61–87.
   PubMed Web of Science ®Google Scholar
• Adachi J, Mori Y, Matsui S, Takigami H, Fujino J, Kitagawa H, Miller CA, Kato T, Saeki K, Matsuda T. 2001. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem. 276:31475–31478.
   PubMed Web of Science ®Google Scholar
• Begum J, Skamnaki VT, Moffatt C, Bischler N, Sarrou J, Skaltsounis AL, Leonidas DD, Oikonomakos NG, Hayes JM. 2015. An evaluation of indirubin analogues as phosphorylase kinase inhibitors. J Mol Graph Model. 61:231–242.
   PubMed Web of Science ®Google Scholar
• Blažević T, Heiss EH, Atanasov AG, Breuss JM, Dirsch VM, Uhrin P. 2015., Indirubin and indirubin derivatives for counteracting proliferative diseases. Evid Based Complement Alternat Med. 2015:654098.
   PubMed Web of Science ®Google Scholar
• Calvo TR, Cardoso CRP, Moura ACS, Dos Santos LC, Colus IM, Vilegas W, Varanda EA. 2011. Mutagenic activity of Indigofera truxillensis and I. suffruticosa aerial parts. Evid Based Complement Alternat Med. 2011:323276.
   PubMedGoogle Scholar
• Cândido-Bacani PM, Mori MP, Calvo TR, Vilegas W, Varanda EA, Cólus IM. 2013. In vitro assessment of the cytotoxic, apoptotic and mutagenic potentials of isatin. J Toxicol Environ Health. 76:354–362.
   PubMed Web of Science ®Google Scholar
• Cândido-Bacani PM, Reis MB, Serpeloni JM, Calvo TR, Vilegas W, Varanda EA, Cólus IM. 2011. Mutagenicity and genotoxicity of isatin in mammalian cells in vivo. Mutat Res. 719:47–51.
   PubMed Web of Science ®Google Scholar
• Cerchiaro G, Aquilano K, Filomeni G, Rotilio G, Ciriolo MR, Ferreira AM. 2005. Isatin-Schiff base copper(II) complexes and their influence on cellular viability. J Inorg Biochem. 99:1433–1440.
   PubMed Web of Science ®Google Scholar
• Chanayath N, Lhieochaiphant S, Phutrakul S. 2002. Pigment extraction techniques from the leaves of Indigofera tinctoria Linn and Baphicacanthus cusia Brem and chemical structure analysis of their major components. CMU J. 1:149–160.
   Google Scholar
• Chang HY, Yang X. 2000. Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Biol Rev. 64:821–846.
   PubMed Web of Science ®Google Scholar
• Choi S-J, Lee J-E, Jeong S-Y, Im I, Lee S-D, Lee E-J, Lee SK, Kwon S-M, Ahn S-G, Yoon J-H, et al. 2010. 5,5'-Substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity. J Med Chem. 53:3696–3706.
   PubMed Web of Science ®Google Scholar
• Cooksey CJ. 2001. Tyrian purple: 6.6′-dibromoindigo and related compounds. Molecules. 6:736–769.
   Web of Science ®Google Scholar
• Cragg GM, Newman DJ. 2013. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta. 1830:3670–3695.
   PubMed Web of Science ®Google Scholar
• Damiens E, Baratte B, Marie D, Eisenbrand G, Meijer L. 2001. Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest. Oncogene. 20:3786–3797.
   PubMed Web of Science ®Google Scholar
• da Silva J, de Freitas TRO, Marinho JR, Speit G, Erdtmann B. 2000. An alkaline single-cell gel electrophoresis (comet) assay for environmental biomonitoring with native rodents. Genet Mol Biol. 23:241–245.
   Web of Science ®Google Scholar
• De Laat WL, Appeldoorn E, Jaspers NG, Hoeijmakers JH. 1998. DNA structural elements required for ERCC1-XPF endonuclease activity. J Biol Chem. 273:7835–7842.
   PubMed Web of Science ®Google Scholar
• De Laat WL, Jaspers NG, Hoeijmakers J. 1999. Molecular mechanism of nucleotide excision repair. Genes Dev. 13:768–785.
   PubMed Web of Science ®Google Scholar
• Eastmond DA, Tucker JD. 1989. Identification of aneuploidy inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody. Environ Mol Mutagen. 13:34–43.
   PubMed Web of Science ®Google Scholar
• Fenech M, Morley A. 1985. Solutions to the kinetic problem in the micronucleus assay. Cytobios. 43:233–246.
   PubMedGoogle Scholar
• Fenech M. 2000. The in vitro micronucleus technique. Mutat Res. 455:81–95.
   PubMed Web of Science ®Google Scholar
• Ferandin Y, Bettayeb K, Kritsanida M, Lozach O, Polychronopoulos P, Magiatis P, Skaltsounis AL, Meijer L. 2006. 3'-Substituted 7-halogenoindirubins, a new class of cell death inducing agents. J Med Chem. 49:4638–4649.
   PubMed Web of Science ®Google Scholar
• Garcez WS, Garcez FR, Barison A. 2003. Additional 3-nitropropanoyl esters of glucose from Indigofera suffruticosa (Leguminosae). Biochem Syst Ecol. 31:207–209.
   Web of Science ®Google Scholar
• Grutter MG. 2000. Caspases: Key players in programmed cell death. Curr Opin Struct Biol. 10:649–655.
   PubMed Web of Science ®Google Scholar
• Guengerich FP, Sorrells JL, Schmitt S, Krauser JA, Aryal P, Meijer L. 2004. Generation of new protein kinase inhibitors utilizing cytochrome P450 mutant enzymes for indigoid synthesis. J Med Chem. 47:3236–3241.
   PubMed Web of Science ®Google Scholar
• Han R. 1994. Highlight on the studies of anticancer drugs derived from plants in China. Stem Cells. 12:53–63.
   PubMed Web of Science ®Google Scholar
• Hasan A, Farman M, Ahmad I. 1994. Flavonoid glycosides from Indigofera hebepetala. Phytochemistry. 35:75–276.
   Web of Science ®Google Scholar
• Hayashi M, Morita T, Kodama Y, Sofuni T, Ishidate Jr M. 1990. The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides. Mutat Res. 245:245–249.
   PubMed Web of Science ®Google Scholar
• Hengartner MO. 2000. The biochemistry of apoptosis. Nature. 407:770–776.
   PubMed Web of Science ®Google Scholar
• Hoessel R, Leclerc S, Endicott JA, Nobel ME, Lawrie A, Tunnah P, Leost M, Damiens E, Marie D, Marko D. 1999. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol. 1:60–67.
   PubMed Web of Science ®Google Scholar
• Hou L, Ju C, Zhang J, Song J, Ge Y, Yue W. 2008. Antitumor effects of isatin on human neuroblastoma cell line (SH-SY5Y) and the related mechanism. Eur J Pharmacol. 589:27–31.
   PubMed Web of Science ®Google Scholar
• Ichimaru Y, Saito H, Uchiyama T, Metori K, Tabata K, Suzuki T, Miyairi S. 2015. Indirubin 3′-(O-oxiran-2-ylmethyl)oxime: a novel anticancer agent. Bioorg Med Chem Lett. 25:1403–1406.
   PubMed Web of Science ®Google Scholar
• Jung ME, Byun BJ, Kim H-M, Lee JY, Park JH, Lee N, Son YH, Choi SU, Yang KM, Kim SJ. 2016. Discovery of indirubin derivatives as new class of DRAK2 inhibitors from high throughput screening. Bioorg Med Chem Lett. 26:2719–2723.
   PubMedGoogle Scholar
• Kameswaran TR, Ramanibai R. 2009. Indirubin-3-monooxime induced cell cycle arrest and apoptosis in Hep-2 human laryngeal carcinoma cells. Biomed Pharmacother. 63:146–154.
   PubMed Web of Science ®Google Scholar
• Kim SA, Kwon SM, Kim JA, Kang KW, Yoon JH, Ahn SG. 2011. 5′-Nitro-indirubinoxime, an indirubin derivative, suppresses metastatic ability of human head and neck cancer cells through the inhibition of Integrin β1/FAK/Akt signaling. Cancer Lett. 306:197–204.
   PubMed Web of Science ®Google Scholar
• Knockaert M, Blondel M, Bach S, Leost M, Elbi C, Hager GL, Nagy SR, Han D, Denison M, Ffrench M, et al. 2004. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene. 23:4400–4412.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Sugiyama C, Morikawa Y, Hayashi M, Sofuny T. 1995. A comparison between manual microscopic analysis and computerized image analysis in the single cell gel electrophoresis assay. MMS Commun. 3:103–115.
   Google Scholar
• Kurita M, Hanada S, Ichimaru Y, Saito H, Tabata K, Asami S, Miyairi S, Suzuki T. 2016. Indirubin 3'-epoxide induces caspase-independent cell death in human neuroblastoma. Biol Pharm Bull. 39:993–999.
   PubMed Web of Science ®Google Scholar
• Lee M-J, Kim M-Y, Mo J-S, Ann EJ, Seo MS, Hong JA, Kim YC, Park HS. 2008. Indirubin-3′-monoxime, a derivative of a Chinese anti-leukemia medicine, inhibits Notch1 signaling. Cancer Lett. 265:215–225.
   PubMed Web of Science ®Google Scholar
• Lee WH, Choi SH, Kang SU, Song CH, Park SJ, Lee YJ, Ku SK. 2016. Genotoxicity testing of Persicariae Rhizoma (Persicaria tinctoria H. Gross) aqueous extracts. Exp Ther Med. 12:123–134.
   PubMed Web of Science ®Google Scholar
• Liu XM, Wang LG, Li HY, Ji XJ. 1996. Induction of differentiation and down-regulation of c-myb gene expression in ML-1 human myeloblastic leukemia cells by the clinically effective anti-leukemia agent meisoindigo. Biochem Pharmacol. 51:1545–1551.
   PubMed Web of Science ®Google Scholar
• Lo WY, Chang NW. 2013. An indirubin derivative, indirubin-3′-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin. PLoS One. 8:e70198.
   PubMed Web of Science ®Google Scholar
• Lorge E, Thybaud V, Aardema MJ, Oliver J, Wakata A, Lorenzon G, Marzin D. 2006. SFTG International Collaborative study on in vitro Micronucleus Test I: General conditions and overall conclusions of the study. Mutat Res. 607:13–16.
   PubMed Web of Science ®Google Scholar
• Manoharan K, Banerjee MR. 1985. beta-Carotene reduces sister chromatid exchanges induced by chemical carcinogens in mouse mammary cells in organ culture. Cell Biol Int Rep. 9:783–789.
   PubMedGoogle Scholar
• Marko D, Friedel A, Genzlinger A, Genzlinger A, Zankl H, Meijer L, Eisenbrand G. 2001. Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells. Br J Cancer. 84:283–289.
   PubMed Web of Science ®Google Scholar
• McGahon AJ, Martin SJ, Bissonnette RP, Mahboubi A, Shi Y, Mogil RJ, Nishioka WK, Green DR. 1995. The end of the (cell) line: methods for the study of apoptosis in vitro. Methods Cell Biol. 46:153–184.
   PubMed Web of Science ®Google Scholar
• Moon MJ, Lee S K, Lee J-W, Song WK, Kim SW, Kim JI, Cho C, Choi SJ, Kim Y-C. 2006. Synthesis and structure-activity relationships of novel indirubin derivatives as potent anti-proliferative agents with CDK2 inhibitory activities. Bioorg Med Chem. 14:237–246.
   PubMed Web of Science ®Google Scholar
• Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65:55–63.
   PubMed Web of Science ®Google Scholar
• Mothana RA, Lindequist U, Gruenert R, Bednarski PJ. 2009. Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra. BMC Complement Altern Med. 9:7.
   PubMed Web of Science ®Google Scholar
• Nam S, Buettner R, Turkson J, Kim D, Cheng JQ, Muehlbeyer S, Hippe F, Vatter S, Merz K.-H, Eisenbrand G, Jove R. 2005. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc Natl Acad Sci USA. 102:5998–6003.
   PubMed Web of Science ®Google Scholar
• Organization for Economic Co-operation and Development (OECD). 2001. Guideline for testing of chemicals no. 423: Acute Oral Toxicity Test. Adopted: 17th December 2001. Paris, France; p. 1–14.
   Google Scholar
• Perabo FGE, Frössler C, Landwehrs G, Schmidt DH, von Rücker A, Wirger A, Müller SC. 2006. Indirubin-3′-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer. Anticancer Res. 26:2129–2136.
   PubMed Web of Science ®Google Scholar
• Perabo FGE, Landwehrs G, Frössler C, Schmidt DH, Mueller SC. 2011. Antiproliferative and apoptosis inducing effects of indirubin-3-monoxime in renal cell cancer cells. Urol Oncol Semin Orig Invest. 29:815–820.
   PubMed Web of Science ®Google Scholar
• Pfaffl MW, Horgan GW, Dempfle L. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30:e36.
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:2002–2007.
   Web of Science ®Google Scholar
• Polychronopoulos P, Magiatis P, Skaltsounis A-L, Myrianthopoulos V, Mikros E, Tarricone A, Musacchio A, Roe S M, Pearl L, Leost M, Greengard P, Meijer L. 2004. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases. J Med Chem. 47:935–946.
   PubMed Web of Science ®Google Scholar
• Sethi G, Ahn KS, Sandur SK, Lin X, Chaturvedi MM, Aggarwal BB. 2006. Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway. J Biol Chem. 281:23425–23435.
   PubMed Web of Science ®Google Scholar
• Shi J, Shen HM. 2008. Critical role of Bid and Bax in indirubin-3′-monoxime-induced apoptosis in human cancer cells. Biochem Pharmacol. 75:1729–1742.
   PubMed Web of Science ®Google Scholar
• Sijbers AM, de Laat WL, Ariza RR, Biggerstaff M, Wei Y-F, Moggs JG, Carter KC, Shell BK, Evans E, de Jong MC, Rademakers S, de Rooij J. 1996. Xeroderma pigmentosum Group F caused by a defect in a structure-specific DNA repair endonuclease. Cell. 86:811–822.
   PubMed Web of Science ®Google Scholar
• Singh NP, McCoy MT, Tice RR, Schneider EL. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 175:184–191.
   PubMed Web of Science ®Google Scholar
• Singh P, Sharma P, Anand A, Bedi PM, Kaur T, Saxena AK, Kumar V. 2012. Azide-alkyne cycloaddition en route to novel 1H-1,2,3-triazole tethered isatin conjugates with in vitro cytotoxic evaluation. Eur J Med Chem. 55:455–461.
   PubMed Web of Science ®Google Scholar
• Song J, Hou L, Ju C, Zhang J, Ge Y, Yue W. 2013. Isatin inhibits proliferation and induces apoptosis of SH-SY5Y neuroblastoma cells in vitro and in vivo. Eur J Pharmacol. 702:235–241.
   PubMed Web of Science ®Google Scholar
• Tice RR, Agurell E, Anderson D, Burlinson B, Hartmann A, Kobayashi H, Miyamae Y, Rojas E, Ryu J-C, Sasaki YF. 2000. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen. 35:206–221.
   PubMed Web of Science ®Google Scholar
• Titenko-Holland N, Windham G, Kolachana P, Reinisch F, Parvatham S, Osorio AM, Smith MT. 1997. Genotoxicity of malathion in human lymphocytes assessed using the micronucleus assay in vitro and in vivo: a study of malathion-exposed workers. Mutat Res. 388:85–95.
   PubMed Web of Science ®Google Scholar
• Vellonen K-S, Honkakoski P, Urtti A. 2004. Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity. Eur J Pharm Sci. 23:181–188.
   PubMed Web of Science ®Google Scholar
• Yu J, Zheng J, Lin J, Jin L, Yu R, Mak S, Hu S, Sun H, Wu X, Zhang Z, Lee M, Tsim W. 2016. Indirubin-3-Oxime prevents H2O2-induced neuronal apoptosis via concurrently inhibiting GSK3β and the ERK pathway. Cell Mol Neurobiol. 37:655–664.
   PubMed Web of Science ®Google Scholar
• Zhang X-M, Guo H, Li Z-S, Song FH, Wang WM, Dai HQ, Zhang LX, Wang JG. 2015. Synthesis and evaluation of isatin-β-thiosemicarbazones as novel agents against antibiotic-resistant Gram-positive bacterial species. Eur J Med Chem. 101:419–430.
   PubMed Web of Science ®Google Scholar
• Zhen Y, Sørensen V, Jin Y, Suo Z, Wiedłocha A. 2007. Indirubin-3′-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK. Oncogene. 26:6372–6385.
   PubMed Web of Science ®Google Scholar